Screener / SEC EDGAR /CIK 0001906324 /10-K filed Feb 19, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Diagnostics

QuidelOrtho Corp QDEL

Compare with peers Embed
FY2025 at a glance

Sales down 1.9%, free cash flow up to -$83.0M

XBRL, from each 10-K
RevenueStatements
$2.7B from $2.8B in FY2024
FY2020FY2025
Net incomeStatements
-$1.1B from -$2.1B in FY2024
FY2020FY2025
Free cash flowStatements
-$83.0M from -$112.1M in FY2024
FY2020FY2025
EPS (diluted)Statements
$-16.69 from $-30.54 in FY2024
FY2020FY2025
Operating marginStatements
-33.7% from -70.5% in FY2024
FY2020FY2025
Total debtStatements
$2.7B from $2.5B in FY2024
FY2020FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (39)
EPS (ttm)
-5.39
Sales (ttm)
2.6B
Net income (ttm)
-369.2M
Sales growth
-1.9%
EPS growth
-
Sales Q/Q
-11.6%
Free cash flow
-117.1M
Gross margin
-
Oper. margin
-4.9%
Net margin
-14.2%
FCF margin
-4.5%
R&D / sales
6.8%
Dividend
-
Debt/Eq
1.64
Curr. ratio
1.36
Cash
166.4M
Op. cash flow (ttm)
7.9M
EBITDA
-477.2M
EBITDA margin
-17.5%
Net debt
2.8B
Quick ratio
0.81
Interest cover
-5.18
FCF after stock pay
-128.9M
Goodwill / assets
0.0%
Oper. margin low 5y
-70.5%
Stock pay / sales
1.7%
Shares out.
68.6M
Shares Y/Y
+0.9%
Book / share
26.11
Cash / share
2.43
Sales / share
37.79
Asset turnover
0.45
Days sales out.
56
Sales 3Y CAGR
-5.8%
Sales 5Y CAGR
+10.5%
Employees
6,500
Sales / employee
399K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2020 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 2.7B +10.4% a year Net income -1.1B
FY2020 revenue 1.7B · Revenues, 0001906324-23-000014 FY2020 net income 810.3M · NetIncomeLoss, 0001906324-23-000014 1.7B FY2020 FY2021 revenue 1.7B · Revenues, 0001906324-24-000043 FY2021 net income 704.2M · NetIncomeLoss, 0001906324-24-000043 1.7B FY2021 FY2022 revenue 3.3B · Revenues, 0001906324-25-000035 FY2022 net income 548.7M · NetIncomeLoss, 0001906324-25-000035 3.3B FY2022 FY2023 revenue 3.0B · Revenues, 0001906324-26-000008 FY2023 net income -10.1M · NetIncomeLoss, 0001906324-26-000008 3.0B FY2023 FY2024 revenue 2.8B · Revenues, 0001906324-26-000008 FY2024 net income -2.1B · NetIncomeLoss, 0001906324-26-000008 2.8B FY2024 FY2025 revenue 2.7B · Revenues, 0001906324-26-000008 FY2025 net income -1.1B · NetIncomeLoss, 0001906324-26-000008 2.7B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2020 to FY2025 (5 years).

Growth per share, FY2020 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Book value per share -1.5% a year FY2020 $30.57 to FY2025 $28.33, 5 years
Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 28, 2025 -$16.69$28.33-$1.22
Dec 29, 2024 -$30.54$44.41-$1.67
Dec 31, 2023 -$0.15$74.94$1.06
Jan 1, 2023 $9.56$85.97$12.97
Jan 2, 2022 $16.43$44.97$11.96
Jan 3, 2021 $18.60$30.57$12.95

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $1.4B
  • − All liabilities $3.8B
  • = Net current asset value -$2.4B
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $1.9B
  • − Other intangible assets $2.6B
  • = Tangible book value -$643.3M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

QDEL against Health care peers

Among the 162 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+4.8%+20.2%
-1.9%141st of 155 · median +10.5%
Net margin
-4.1%15.3%
-14.2%126th of 154 · median 6.8%
Return on equity
-5.2%18.5%
-20.6%116th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
-4.5%121st of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
1.6493rd of 108 · median 0.69
QDEL and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
QDEL QuidelOrtho Corp$2.6B -1.9%--14.2%-20.6%-4.5%1.64
CHE Chemed Corp$2.7B +4.1%33.5%10.6%32.8%11.1%0.27
RPRX Royalty Pharma plc$2.6B +5.1%-25.7%6.9%-0.88
MRNA Moderna$2.5B -39.9%--110.5%-40.8%-78.0%0.09
EXEL Exelixis, Inc.$2.5B +7.0%96.3%35.5%48.3%46.5%-
PRVA Privia Health Group, Inc.$2.4B +22.3%-1.4%4.3%--
All 162 companies in the group

Where the $2.7B of revenue came from

by segment, year to Dec 28, 2025

  • North America $1.5B · 55%
  • EMEA $360.7M · 13%
  • China $334.7M · 12%
  • JPAC $293.0M · 11%
  • Latin America $252.9M · 9%

From the segment tables in the 10-K XBRL.

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2021 · 10-K XBRL, year-end balances

Return on equity -58.9% FY2021: 36.5% net income ÷ equity
Net margin -41.5% FY2021: 41.5% profit per $ of sales: -1.1B ÷ 2.7B
Asset turnover 0.47× FY2021: 0.70× sales per $ of assets: 2.7B ÷ 5.8B
Leverage 3.00× FY2021: 1.26× assets per $ of equity: 5.8B ÷ 1.9B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    -14.2% vs 6.8%
  • Return on equity below 15%
    -20.6%
  • A profit in 3 of 6 years
Net margin, FY2020 to FY2025: 48.8% to -41.5%

Balance sheet

  • Interest covered less than 5 times
    Operating income is -5.2× interest expense
  • Debt larger than equity
    Debt / equity 1.64 on the latest balance sheet (peer median 0.69)
  • Current assets cover current liabilities
    Current ratio 1.36
Debt / equity at each year end, FY2020 to FY2025: 0.00 to 1.40

Cash and shareholders

  • Free cash flow positive in 4 of 6 years
    −$83.0M last year
  • Share count up over 5 years
    +55.5%
Free cash flow, FY2020 to FY2025: 564.8M to -83.0M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

$2.7B of principal due, schedule of Dec 28, 2025

Debt

Repayment schedule

From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Contract liabilities

Paid in advance $49.8M cash received before delivery, not yet recognized as revenue, Sep 27, 2026 · -2.4% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

QDEL's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 6. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue2.7B
FY2020: 1.7BFY2021: 1.7BFY2022: 3.3BFY2023: 3.0BFY2024: 2.8BFY2025: 2.7B FY2020FY2021FY2022FY2023FY2024FY2025
Net income-1.1B
FY2020: 810.3MFY2021: 704.2MFY2022: 548.7MFY2023: -10.1MFY2024: -2.1BFY2025: -1.1B FY2020FY2021FY2022FY2023FY2024FY2025
Free cash flow-83.0M
FY2020: 564.8MFY2021: 513.1MFY2022: 744.4MFY2023: 70.9MFY2024: -112.1MFY2025: -83.0M FY2020FY2021FY2022FY2023FY2024FY2025
Free cash flow after stock pay-128.9M
FY2020: 543.8MFY2021: 487.7MFY2022: 696.0MFY2023: 19.3MFY2024: -154.2MFY2025: -128.9M FY2020FY2021FY2022FY2023FY2024FY2025
EPS (diluted)-16.69
FY2020: 18.60FY2021: 16.43FY2022: 9.56FY2023: -0.15FY2024: -30.54FY2025: -16.69 FY2020FY2021FY2022FY2023FY2024FY2025
Diluted shares67.8M
FY2020: 43.6MFY2021: 42.9MFY2022: 57.4MFY2023: 66.8MFY2024: 67.2MFY2025: 67.8M FY2020FY2021FY2022FY2023FY2024FY2025

The segments changed

10-K filed Feb 19, 2026

Compared with the 10-K of Feb 27, 2025: new segments JPAC, Latin America .

When a company changes its segments, the years before are usually recast, so growth by segment is not comparable with what earlier 10-Ks showed. Found by comparing the segments with revenue in the last two 10-Ks (XBRL) and by the 10-K's own words, without AI.

Revenue by business segment

year to Dec 28, 2025
RevenueSharevs year before
North America 1.5B54.5% -8.1%
EMEA 360.7M13.2% +7.4%
China 334.7M12.3% +3.0%
JPAC 293.0M10.7% +4.9%
Latin America 252.9M9.3% +13.5%

10-K 0001906324-26-000008, segment and revenue notes (XBRL).

Revenue by region

year to Dec 28, 2025
RevenueSharevs year before
Domestic 1.4B52.6% -8.4%
Foreign 1.3B47.4% +6.5%

10-K 0001906324-26-000008, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
North America1.5B2.5B1.9B1.6B1.5B
EMEA69.6M206.8M327.3M335.8M360.7M
China-220.0M310.1M325.0M334.7M
JPAC--272.7M279.4M293.0M
Latin America--210.6M222.9M252.9M
China58.0M220.0M310.1M--
Other70.8M302.7M483.3M--

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Segments changed: FY2021, FY2022, FY2023 are in italics, as first reported under the earlier segments, so they are not comparable with the later years. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1.7B1.7B3.3B3.0B2.8B2.7B
R&D84.3M95.7M187.9M245.0M218.7M186.2M
SG&A180.7M239.6M621.0M763.2M766.8M746.3M
Operating income1.1B906.0M843.7M139.1M-2.0B-919.2M
Interest expense500K075.7M147.6M163.5M177.6M
Pretax income1.0B900.3M735.9M-29.1M-2.1B-1.1B
Income tax230.0M196.1M187.2M-19.0M-79.5M24.1M
Net income810.3M704.2M548.7M-10.1M-2.1B-1.1B
EPS (diluted)18.6016.439.56-0.15-30.54-16.69
Diluted shares43.6M42.9M57.4M66.8M67.2M67.8M
Depreciation & amortization48.8M52.7M283.6M457.2M453.4M442.0M
EBITDA1.1B958.7M1.1B596.3M-1.5B-477.2M
Operating margin63.8%53.3%25.8%4.6%-70.5%-33.7%
Net margin48.8%41.5%16.8%-0.3%-73.7%-41.5%
Revenue growth-+2.2%+92.3%-8.2%-7.2%-1.9%
EPS growth--11.7%-41.8%to a loss--

Balance sheet

From EDGAR
FY2020FY2021FY2022FY2023FY2024FY2025
Cash489.9M802.8M292.9M118.9M98.3M169.8M
Short-term investments-25.7M52.1M48.4M0-
Receivables-378.0M453.9M303.3M282.4M417.0M
Inventory-198.8M524.1M577.8M533.7M577.6M
Current assets-1.4B1.6B1.3B1.2B1.4B
Property & equipment-349.2M1.3B1.4B--
Goodwill-337.0M2.5B2.5B649.5M0
Other intangible assets-98.7M3.1B2.9B2.7B2.6B
Total assets-2.4B8.9B8.6B6.4B5.8B
Accounts payable-101.5M283.3M294.8M246.0M279.4M
Current liabilities-323.5M1.0B833.8M998.8M966.1M
Total debt-1.0M2.6B2.4B2.5B2.7B
Total liabilities-501.0M3.9B3.6B3.4B3.8B
Shareholders' equity1.3B1.9B4.9B5.0B3.0B1.9B
Retained earnings-1.6B2.2B2.2B135.8M-996.0M

Cash flow

From EDGAR
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow629.7M805.9M885.3M280.2M83.0M105.2M
Capital spending64.9M292.8M140.9M209.3M195.1M188.2M
Free cash flow564.8M513.1M744.4M70.9M-112.1M-83.0M
Stock-based pay (added back)21.0M25.4M48.4M51.6M42.1M45.9M
Free cash flow after stock pay543.8M487.7M696.0M19.3M-154.2M-128.9M
Buybacks43.7M103.5M74.3M7.2M00
Acquisitions001.5B00-
Debt raised002.7B002.6B
Debt repaid---228.0M143.0M2.3B
Investing cash flow-63.3M-319.5M-1.6B-187.6M-149.9M-192.7M
Financing cash flow-130.3M-173.1M252.0M-265.8M48.8M155.8M

Stock-based pay and leases

From EDGAR
FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)21.0M25.4M48.4M51.6M42.1M45.9M
Stock-based pay / revenue1.3%1.5%1.5%1.7%1.5%1.7%
Operating lease cost11.2M15.4M26.4M38.4M40.4M33.1M
Operating lease cash paid10.8M12.3M25.2M36.5M38.9M42.4M
Finance lease principal paid500K300K2.4B228.0M143.0M-
Right-of-use assets-127.6M181.0M169.6M168.7M155.5M
Operating lease liabilities-138.6M210.8M199.5M198.3M183.7M
Finance lease liabilities---400K7.9M1.6M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/QDEL/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.